Amuamuta A, Plengsuriyakarn T, Na-Bangchang K
BMC Complement Altern Med. 2017; 17(1):213.
PMID: 28403856
PMC: 5389435.
DOI: 10.1186/s12906-017-1713-4.
Burkhardt J, Riina H, Shin B, Moliterno J, Hofstetter C, Boockvar J
Interv Neuroradiol. 2011; 17(3):286-95.
PMID: 22005689
PMC: 3396041.
DOI: 10.1177/159101991101700302.
Lee K, Rhee K
Cancer Res Treat. 2009; 37(3):196-200.
PMID: 19956503
PMC: 2785405.
DOI: 10.4143/crt.2005.37.3.196.
Chen J, Wang S, Tang R, Yang Q, Zhao E, Chao Y
Mol Biol Rep. 2002; 29(3):287-92.
PMID: 12463421
DOI: 10.1023/a:1020479301379.
Teicher B, Menon K, Alvarez E, Shih C, Faul M
Invest New Drugs. 2002; 20(3):241-51.
PMID: 12201487
DOI: 10.1023/a:1016297611825.
Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases.
Kruczynski A, Etievant C, Perrin D, Imbert T, Colpaert F, Hill B
Br J Cancer. 2000; 83(11):1516-24.
PMID: 11076662
PMC: 2363411.
DOI: 10.1054/bjoc.2000.1428.
A microcomputer program for calculating cell population doubling time in vitro and in vivo.
Zwicker J, Proffitt R, Reynolds C
Cancer Chemother Pharmacol. 1996; 37(3):203-10.
PMID: 8529279
DOI: 10.1007/BF00688318.
Considerations in the use of nude mice for cancer research.
Sharkey F, Fogh J
Cancer Metastasis Rev. 1984; 3(4):341-60.
PMID: 6394126
DOI: 10.1007/BF00051459.
Predictive tests in cancer chemotherapy. A reappraisal.
Osieka R, Seeber S, SCHMIDT C
Klin Wochenschr. 1984; 62(5):203-12.
PMID: 6371370
DOI: 10.1007/BF01721045.
Predictive testing in cancer chemotherapy. I. In vivo.
Slee P, Van Oosterom A, de Bruijn E
Pharm Weekbl Sci. 1985; 7(3):93-9.
PMID: 3895154
DOI: 10.1007/BF01968709.
Application of a new preclinical drug screening system for cancer of the large bowel.
Scheithauer W, Moyer M, Clark G, Von Hoff D
Cancer Chemother Pharmacol. 1988; 21(1):31-4.
PMID: 3342463
DOI: 10.1007/BF00262734.
Postconfluency MDCK monolayers as an in vitro model of solid tumor chemosensitivity.
Skehan P, Thomas J, Friedman S
Cell Biol Toxicol. 1986; 2(3):357-68.
PMID: 3267455
DOI: 10.1007/BF00121851.
Activity of batracylin (NSC-320846) against solid tumors of mice.
Mucci-LoRusso P, Polin L, Bissery M, Valeriote F, Plowman J, Luk G
Invest New Drugs. 1989; 7(4):295-306.
PMID: 2557298
DOI: 10.1007/BF00173759.
Determination of subcutaneous tumor size in athymic (nude) mice.
Tomayko M, Reynolds C
Cancer Chemother Pharmacol. 1989; 24(3):148-54.
PMID: 2544306
DOI: 10.1007/BF00300234.
Expression of neurophysin-related precursor in cell membranes of a small-cell lung carcinoma.
Rosenbaum L, Neuwelt E, Van Tol H, Loh Y, Verbalis J, Hellstrom I
Proc Natl Acad Sci U S A. 1990; 87(24):9928-32.
PMID: 1702222
PMC: 55287.
DOI: 10.1073/pnas.87.24.9928.
